S&P 500   4,701.21 (+0.31%)
DOW   35,754.75 (+0.10%)
QQQ   399.43 (+0.40%)
AAPL   175.25 (+2.38%)
MSFT   334.92 (+0.00%)
FB   330.83 (+2.48%)
GOOGL   2,963.73 (+0.62%)
AMZN   3,517.60 (-0.16%)
TSLA   1,066.01 (+1.36%)
NVDA   317.90 (-1.96%)
BABA   125.18 (-0.29%)
NIO   35.05 (+5.83%)
CGC   10.93 (+2.73%)
AMD   145.15 (+0.21%)
GE   98.46 (+0.93%)
MU   85.97 (+0.16%)
T   23.17 (+0.39%)
F   19.83 (-0.65%)
DIS   153.40 (+1.72%)
PFE   51.43 (-0.56%)
AMC   32.03 (+3.19%)
ACB   6.59 (+3.29%)
BA   211.05 (+1.06%)
S&P 500   4,701.21 (+0.31%)
DOW   35,754.75 (+0.10%)
QQQ   399.43 (+0.40%)
AAPL   175.25 (+2.38%)
MSFT   334.92 (+0.00%)
FB   330.83 (+2.48%)
GOOGL   2,963.73 (+0.62%)
AMZN   3,517.60 (-0.16%)
TSLA   1,066.01 (+1.36%)
NVDA   317.90 (-1.96%)
BABA   125.18 (-0.29%)
NIO   35.05 (+5.83%)
CGC   10.93 (+2.73%)
AMD   145.15 (+0.21%)
GE   98.46 (+0.93%)
MU   85.97 (+0.16%)
T   23.17 (+0.39%)
F   19.83 (-0.65%)
DIS   153.40 (+1.72%)
PFE   51.43 (-0.56%)
AMC   32.03 (+3.19%)
ACB   6.59 (+3.29%)
BA   211.05 (+1.06%)
S&P 500   4,701.21 (+0.31%)
DOW   35,754.75 (+0.10%)
QQQ   399.43 (+0.40%)
AAPL   175.25 (+2.38%)
MSFT   334.92 (+0.00%)
FB   330.83 (+2.48%)
GOOGL   2,963.73 (+0.62%)
AMZN   3,517.60 (-0.16%)
TSLA   1,066.01 (+1.36%)
NVDA   317.90 (-1.96%)
BABA   125.18 (-0.29%)
NIO   35.05 (+5.83%)
CGC   10.93 (+2.73%)
AMD   145.15 (+0.21%)
GE   98.46 (+0.93%)
MU   85.97 (+0.16%)
T   23.17 (+0.39%)
F   19.83 (-0.65%)
DIS   153.40 (+1.72%)
PFE   51.43 (-0.56%)
AMC   32.03 (+3.19%)
ACB   6.59 (+3.29%)
BA   211.05 (+1.06%)
S&P 500   4,701.21 (+0.31%)
DOW   35,754.75 (+0.10%)
QQQ   399.43 (+0.40%)
AAPL   175.25 (+2.38%)
MSFT   334.92 (+0.00%)
FB   330.83 (+2.48%)
GOOGL   2,963.73 (+0.62%)
AMZN   3,517.60 (-0.16%)
TSLA   1,066.01 (+1.36%)
NVDA   317.90 (-1.96%)
BABA   125.18 (-0.29%)
NIO   35.05 (+5.83%)
CGC   10.93 (+2.73%)
AMD   145.15 (+0.21%)
GE   98.46 (+0.93%)
MU   85.97 (+0.16%)
T   23.17 (+0.39%)
F   19.83 (-0.65%)
DIS   153.40 (+1.72%)
PFE   51.43 (-0.56%)
AMC   32.03 (+3.19%)
ACB   6.59 (+3.29%)
BA   211.05 (+1.06%)
NYSE:GKOS

Glaukos News Headlines

$44.09
+0.71 (+1.64%)
(As of 12/8/2021 03:59 PM ET)
Add
Compare
Today's Range
$43.52
▼
$44.60
50-Day Range
$40.27
▼
$56.99
52-Week Range
$39.35
▼
$99.00
Volume
16,976 shs
Average Volume
514,258 shs
Market Capitalization
$2.07 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.69

Media Mentions By Week



Glaukos Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GKOS
News Sentiment
▼
0.33

0.33
▲
Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GKOS Articles
This Week
▼
1

4
▲
GKOS Articles
Average Week

Get Glaukos News Delivered to You Automatically

Sign up to receive the latest news and ratings for GKOS and its competitors with MarketBeat's FREE daily newsletter.

Glaukos (NYSE:GKOS) News Headlines Today

SourceHeadline
MarketBeat logoGlaukos (NYSE:GKOS) Sets New 1-Year Low at $42.23
americanbankingnews.com - November 30 at 2:12 PM
nasdaq.com logoAsian Markets Nervous As Omicron Spread Haunts - Nasdaq
nasdaq.com - November 30 at 8:32 AM
fool.com logoGlaukos Corp (GKOS) FY 2021 Earnings Call Transcript - Motley Fool
fool.com - November 30 at 7:13 AM
businesswire.com logoGlaukos Technologies Featured in Numerous Scientific Abstracts at the 2021 American Academy of Ophthalmology Annual Meeting - Business Wire
businesswire.com - November 11 at 3:08 PM
benzinga.com logoFDA Clears Sight Sciences' Trial Of Canaloplasty Combined With Cataract Surgery To Lower Ocular Pressure - Benzinga
benzinga.com - November 11 at 8:54 AM
finance.yahoo.com logoGlaukos Technologies Featured in Numerous Scientific Abstracts at the 2021 American Academy of Ophthalmology Annual Meeting - Yahoo Finance
finance.yahoo.com - November 11 at 8:54 AM
finance.yahoo.com logoGlaukos Technologies Featured in Numerous Scientific Abstracts at the 2021 American Academy of Ophthalmology Annual Meeting
finance.yahoo.com - November 11 at 8:54 AM
finance.yahoo.com logoSight Sciences Announces FDA Authorization for the PRECISION Trial, a Groundbreaking Three-Arm Randomized, Controlled IDE Trial of Canal Viscodilation in Combination with Cataract Surgery in Adults with Primary Open-Angle Glaucoma (POAG) - Yahoo Finance
finance.yahoo.com - November 10 at 11:33 PM
finance.yahoo.com logoGlaukos (GKOS) Gains 3.6% Despite Reporting a Loss in Q3
finance.yahoo.com - November 8 at 3:41 PM
seekingalpha.com logoGlaukos Corporation (GKOS) CEO Tom Burns on Q3 2021 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - November 8 at 10:37 AM
fool.com logoGlaukos Corp (GKOS) Q3 2021 Earnings Call Transcript - Motley Fool
fool.com - November 7 at 1:28 PM
finance.yahoo.com logoGlaukos Corp (GKOS) Q3 2021 Earnings Call Transcript
finance.yahoo.com - November 7 at 1:28 PM
businesswire.com logoGlaukos Corporation Announces Third Quarter 2021 Financial Results - Business Wire
businesswire.com - November 4 at 5:33 PM
finance.yahoo.com logoGlaukos Corporation Announces Third Quarter 2021 Financial Results
finance.yahoo.com - November 4 at 5:33 PM
finance.yahoo.com logo25 Stocks Moving in Wednesday's Pre-Market Session - Yahoo Finance
finance.yahoo.com - November 3 at 11:57 PM
seekingalpha.com logoGlaukos Q3 2021 Earnings Preview - Seeking Alpha
seekingalpha.com - November 3 at 6:56 PM
finance.yahoo.com logo54 Stocks Moving In Wednesday's Mid-Day Session - Yahoo Finance
finance.yahoo.com - November 3 at 3:45 PM
finance.yahoo.com logoGlaukos Stock Jumps After Upgrade on Medicare Reimbursement Rules - Yahoo Finance
finance.yahoo.com - November 3 at 3:45 PM
nasdaq.com logoPolitical spotlight on Carlyle after U.S. election - Nasdaq
nasdaq.com - November 3 at 1:56 PM
streetinsider.com logoForm 8-K GLAUKOS Corp For: Nov 02 - StreetInsider.com
streetinsider.com - November 3 at 1:56 PM
fool.com logoWhy Glaukos Stock Is Soaring Today - Motley Fool
fool.com - November 3 at 1:56 PM
finance.yahoo.com logoWhy Glaukos Stock Is Soaring Today
finance.yahoo.com - November 3 at 1:56 PM
nasdaq.com logoWhy Is Glaukos Surging? - Nasdaq
nasdaq.com - November 3 at 10:44 AM
seekingalpha.com logoiRhythm, Glaukos surge after updates on Medicare reimbursement rates - Seeking Alpha
seekingalpha.com - November 3 at 8:55 AM
businesswire.com logo2021 Report on the Keratoconjunctivitis Sicca Drugs In Development - ResearchAndMarkets.com - Business Wire
businesswire.com - November 2 at 12:57 AM
finance.yahoo.com logoHedge Funds Are Warming Up To Glaukos Corporation (GKOS) - Yahoo Finance
finance.yahoo.com - October 29 at 2:04 PM
finance.yahoo.com logoHedge Funds Are Warming Up To Glaukos Corporation (GKOS)
finance.yahoo.com - October 29 at 12:00 PM
finance.yahoo.com logoGlobal Refractive Surgery Devices Market By Application, By Product, By End Use, By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027 - Yahoo Finance
finance.yahoo.com - October 26 at 10:59 AM
finance.yahoo.com logoHedge Funds Are Crazy About Option Care Health, Inc. (OPCH) - Yahoo Finance
finance.yahoo.com - October 18 at 12:05 PM
businesswire.com logoGlaukos Corporation to Release Third Quarter 2021 Financial Results after Market Close on November 4 - Business Wire
businesswire.com - October 14 at 8:08 AM
finance.yahoo.com logoGlaukos Corporation to Release Third Quarter 2021 Financial Results after Market Close on November 4
finance.yahoo.com - October 14 at 8:08 AM
finance.yahoo.com logoIs Glaukos (NYSE:GKOS) Using Too Much Debt?
finance.yahoo.com - October 11 at 10:16 AM
businesswire.com logoGlaukos Technologies Featured in Numerous Scientific Abstracts at the 2021 European Society of Cataract and Refractive Surgeons Annual Meeting - Business Wire
businesswire.com - October 7 at 5:10 PM
finance.yahoo.com logoGlaukos Technologies Featured in Numerous Scientific Abstracts at the 2021 European Society of Cataract and Refractive Surgeons Annual Meeting
finance.yahoo.com - October 7 at 5:10 PM
finance.yahoo.com logoGlobal Surgical Eye Care Market Report 2021 Featuring Alcon, Johnson & Johnson, Carl Zeiss, The Cooper Companies, Bausch Health, Hoya, STAAR Surgical, Topcon, Nidek and Glaukos - Yahoo Finance
finance.yahoo.com - October 6 at 8:30 PM
nasdaq.com logoGlaukos Corporation Shares Fall 0.4% Below Previous 52-Week Low - Market Mover - Nasdaq
nasdaq.com - October 4 at 9:16 PM
finance.yahoo.com logoGlaukos- A Clear Vision for Eyecare
finance.yahoo.com - October 1 at 4:17 AM
nasdaq.com logoHealth Check: How Prudently Does Glaukos (NYSE:GKOS) Use Debt? - Nasdaq
nasdaq.com - September 27 at 8:44 AM
nasdaq.com logoHere's Why You Should Hold on to Glaukos (GKOS) Stock Now - Nasdaq
nasdaq.com - September 20 at 1:22 PM
finance.yahoo.com logoHere's Why You Should Hold on to Glaukos (GKOS) Stock Now
finance.yahoo.com - September 20 at 1:22 PM
businesswire.com logoGlaukos Announces Licensing Agreement with Attillaps Holdings, Inc. - Business Wire
businesswire.com - September 20 at 7:50 AM
finance.yahoo.com logoGlaukos Announces Licensing Agreement with Attillaps Holdings, Inc.
finance.yahoo.com - September 20 at 7:50 AM
finance.yahoo.com logoIvantis To Pay $60M In Patent Litigation Settlement With Glaukos
finance.yahoo.com - September 15 at 2:42 PM
finance.yahoo.com logoNew Found Intercepts More High-Grade Gold at Keats; Extends Zone 200m Vertically Towards Surface - Yahoo Finance
finance.yahoo.com - September 15 at 9:42 AM
finance.yahoo.com logoGlaukos Announces Settlement of Patent Litigation with Ivantis, Inc.
finance.yahoo.com - September 15 at 9:42 AM
finance.yahoo.com logoGlaukos (GKOS) Announces PMA Submission, Boosts iStent Platform - Yahoo Finance
finance.yahoo.com - September 10 at 7:28 AM
nasdaq.com logoGlaukos (GKOS) Announces PMA Submission, Boosts iStent Platform - Nasdaq
nasdaq.com - September 9 at 4:16 PM
finance.yahoo.com logoGlaukos (GKOS) Announces PMA Submission, Boosts iStent Platform
finance.yahoo.com - September 9 at 4:16 PM
businesswire.com logoGlobal Glaucoma Surgery Devices Markets Report 2021: Increasing Innovations and Technological Developments - Forecast to 2025 - ResearchAndMarkets.com - Business Wire
businesswire.com - September 7 at 6:59 AM
finance.yahoo.com logoHere’s Why Artisan Partners Sold its Glaukos Corporation (GKOS) Position - Yahoo Finance
finance.yahoo.com - September 6 at 3:57 PM
Get Glaukos News Delivered to You Automatically

Sign up to receive the latest news and ratings for GKOS and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 12/8/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.